English English
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Education

Hemophilia Gene Therapy - Key Components of Clinical Care

Virtual Learning Sessions

Presented by Michael Makris, MA, MB BS, MD, FRCP, FRCPath, Wolfgang Miesbach, MD, PhD, and Flora Peyvandi, MD, PhD

Follow-up on a Novel Adeno-Associated Virus (AAV) Gene Therapy (FLT180a) Achieving Normal FIX Activity Levels in Severe Hemophilia B (HB) Patients (B-AMAZE Study)

Conference Coverage

Pratima Chowdary, MRCP, FRCPath

Characterisation of Adeno-Associated Virus Vector Persistence After Long-Term Follow-up in the Haemophilia A Dog Model

Conference Coverage

Paul Batty, MBBS, PhD

Efficacy and Safety of Etranacogene Dezaparvovec in Adults With Severe or Moderate-severe Hemophilia B: First Data From the Phase 3 Hope-B Gene Therapy Trial

Conference Coverage

Steven W. Pipe, MD

Etranacogene Dezaparvovec (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults With Severe or Moderate-Severe Hemophilia B

Conference Coverage

Annette von Drygalski, MD, PharmD

Long-term Outcomes: Durability and Safety

Interactive Webinars

Presented by Prof. Margareth C. Ozelo, MD, PhD

Key Considerations: Advances in Gene Therapy for Hemophilia ENDURING

Virtual Learning Sessions

Presented by Glenn Pierce, MD, PhD, Lindsey George, MD, Alfonso Iorio, MD, Barbara Konkle, MD

EAHAD Gene Therapy Working Group

Podcasts

Presented by Wolfgang Miesbach, MD

ISTH Gene Therapy for Hemophilia Initiative and the Role of EAHAD

Podcasts

Presented by Flora Peyvandi, MD, PhD

History of EAHAD and the Upcoming Congress

Podcasts

Presented by Aislin Ryan, the CEO of EAHAD

Hemophilia Gene Therapy: Expectations for Reliability and Accessibility

Podcasts

Presented by Andrew Leavitt, MD

First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology in Severe Hemophilia A – BAY 2599023 has Broad Patient Eligibility and Stable and Sustained Long-Term Expression of FVIII

Conference Coverage

Steven W. Pipe, MD

Etranacogene Dezaparvovec (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults With Severe or Moderate-Severe Hemophilia B: Two Year Data From a Phase 2b Trial

Conference Coverage

Steven W. Pipe, MD 

First Data From the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults With Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing

Conference Coverage

Steven W. Pipe, MD

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B Confirm Stable FIX Expression and Durable Reductions in Bleeding and Factor IX Consumption for Up to 5 Years

Conference Coverage

Wolfgang A. Miesbach, MD

Updated Follow-up of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (SB-525) Gene Therapy in Adults With Severe Hemophilia

Conference Coverage

Barbara A. Konkle, MD

Latest Advances in Gene Therapy for Hemophilia in Portuguese

Podcasts

Presented by Margareth Ozelo, MD, PhD

Obstacles and Opportunities

Interactive Webinars

Presented by Frank W.G. Leebeek, MD, PhD

Key Considerations: Advances in Gene Therapy for Hemophilia

Virtual Learning Sessions

Presented by Glenn Pierce, MD, PhD, Lindsey George, MD, Alfonso Iorio, MD, Barbara Konkle, MD

The Safety of Hemophilia Gene Therapy Now and in the Future

Podcasts

Presented by Michael Makris, MA, MB BS, MD, FRCP, FRCPath

Lentivirus Vectors for Hemophilia Gene Therapy

Podcasts

Presented by Glenn F. Pierce, MD, PhD and Robert Peters, PhD

WFH Gene Therapy Registry

Podcasts

Presented by Barbara A. Konkle, MD and Johnny Mahlangu, BSc, MBBCh, MMed, FCPath

Stepping Into the Future: Hemophilia Gene Therapy Clinical Trial Updates

Virtual Learning Sessions

Presented by Flora Peyvandi, MD, PhD, Glenn Pierce, MD, PhD, and Steven W. Pipe, MD

Patient Support, Patient Counseling, and Monitoring

Interactive Webinars

Presented by Lindsey A. George, MD

Subcategories

Interactive Webinars

Expert of the Month Interviews

Back To Top
Image

Please enable the javascript to submit this form

About

Supported by educational grants from Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, and uniQure, Inc.

Essential SSL